Significance of early tubular extraction in the first minute of Tc-99m MAG3 renal transplant scintigraphy

被引:10
作者
Lin, E [1 ]
Alavi, A [1 ]
机构
[1] Hosp Univ Penn, Div Nucl Med, Philadelphia, PA 19104 USA
关键词
Kidney Transplantation; radioisotope renography; Tc-99m MAG3;
D O I
10.1097/00003072-199804000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Renal transplant perfusion curves obtained using Tc-99m MAG3 differ from those with Tc-99m DTPA. The perfusion curve can be divided into a first phase (up to the first-pass peak) and a second phase (the curve after the initial peak). The second phase of the MAG3 perfusion curve is usually ascending in contrast to the descending Tc-99m DTPA curve. This ascending MAG3 curve reflects early tubular extraction of MAG3, However, the second phase of the MAG3 curve is sometimes flat or descending. We hypothesized that a flat or descending curve reflects poor early tubular extraction acid therefore graft dysfunction. Ninety-two studies of 59 renal transplant patients were retrospectively reviewed. The second phase of the perfusion curve was visually classified as ascending, flat, or descending. 77.2% of studies had ascending curves, 16.3% flat curves, and 6.5% descending curves. A descending curve had a positive predictive value (PPV) of 100% for medical graft dysfunction, while a flat curve had a PPV of 93.3%. A nonascending second phase curve was specific (96.4%) but not sensitive (33.9%) for graft dysfunction. Patients with acute tubular necrosis were not significantly more likely to have a nonascending curve than those with acute rejection. There was no significant difference in creatinine level between patients with medical graft dysfunction and ascending vs. nonascending curves. A nonascending second phase Tc-99m MAG3 perfusion curve is predictive for graft dysfunction. An ascending curve is nonspecific and can be seen in both normally and poorly functioning grafts.
引用
收藏
页码:217 / 222
页数:6
相关论文
共 31 条
[1]   CLINICAL-EXPERIENCE WITH TC-99M-MAG3, MERCAPTOACETYLTRIGLYCINE, AND A COMPARISON WITH TC-99M-DTPA [J].
ALNAHHAS, AA ;
JAFRI, RA ;
BRITTON, KE ;
SOLANKI, K ;
BOMANJI, J ;
MATHER, S ;
CARROLL, MA ;
ALJANABI, M ;
FRUSCIANTE, V ;
AJDINOWIC, B ;
FIORE, F ;
DEMENA, S ;
NIMMON, CC .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (9-10) :453-462
[2]  
BAJEN MT, 1992, TRANSPLANT P, V24, P60
[3]  
BANNISTER KM, 1990, J NUCL MED, V31, P1568
[4]  
BUBECK B, 1990, J NUCL MED, V31, P1385
[5]   DIAGNOSIS OF IMPAIRED RENAL-FUNCTION AFTER KIDNEY-TRANSPLANTATION USING RENAL SCINTIGRAPHY, RENAL PLASMA-FLOW AND URINARY-EXCRETION OF HIPPURATE [J].
DIETHELM, AG ;
DUBOVSKY, EV ;
WHELCHEL, JD ;
HARTLEY, MW ;
TAUXE, WN .
ANNALS OF SURGERY, 1980, 191 (05) :604-616
[6]   RADIONUCLIDE EVALUATION OF RENAL-TRANSPLANTS [J].
DUBOVSKY, EV ;
RUSSELL, CD ;
ERBAS, B .
SEMINARS IN NUCLEAR MEDICINE, 1995, 25 (01) :49-59
[7]  
DUBOVSKY EV, 1990, CONTRIB NEPHROL, V79, P118
[8]  
DUBOVSKY EV, 1990, SEMIN NUCL MED, V79, P118
[9]   TC-99M RENAL TUBULAR FUNCTION AGENTS - CURRENT STATUS [J].
ESHIMA, D ;
FRITZBERG, AR ;
TAYLOR, A .
SEMINARS IN NUCLEAR MEDICINE, 1990, 20 (01) :28-40
[10]  
FRAILE M, 1989, EUR J NUCL MED, V15, P776